Family Medicine Doctors in Warren, IN Accepting Medicare
2 Family Medicine doctors found. Showing 1 - 2
 Dr. Victoria R Heinen, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 824 Huntington Ave, Warren, IN 46792 Phone: 260-375-2965 Fax: 260-479-2992 |
Dr. Deborah L Miller, M.D. Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 824 Huntington Ave, Warren, IN 46792 Phone: 260-375-2965 Fax: 260-375-2969 |
News Archive
Prefrontal glutamate abnormalities confined to established psychosis
Abnormalities in glutamate and glutamine levels in the prefrontal cortex are only present in patients with chronic schizophrenia, say researchers.
AAO-MEACO Meeting highlights data on glaucoma risk in people with migraine, innovative uses of digital technology
Data on glaucoma risk in people with migraine and on innovative uses of mobile, digital technology are featured in today's Scientific Program, to be presented at the 2010 American Academy of Ophthalmology (AAO) - Middle East-Africa Council of Ophthalmology (MEACO) Joint Meeting.
New 3D scaffolding technology may help grow skin and blood vessels in labs
Scientists are developing new scaffolding technology which could be used to grow tissues such as skin, nerves and cartilage using 3D spaghetti-like structures. Their research is highlighted in the latest issue of Business, the quarterly highlights magazine of the Biotechnology and Biological Sciences Research Council (BBSRC).
Miniaturized wireless sensors can save lives of wounded soldiers
Early detection of blood loss to save the lives of soldiers wounded on the battlefield is the goal of a three-year research and development project to be launched this fall at Worcester Polytechnic Institute (WPI). Funded by a $1.9 million grant from the U.S. Army, the research will be conducted in collaboration with the University of Massachusetts Medical School (UMMS).
Mallinckrodt's subsidiary to acquire all outstanding shares of Cadence Pharmaceuticals
Mallinckrodt plc, a leading global specialty pharmaceuticals company, and Cadence Pharmaceuticals, Inc. today announced that they have entered into a definitive agreement under which a subsidiary of Mallinckrodt plc will commence a tender offer to acquire all outstanding shares of Cadence Pharmaceuticals, Inc. for $14.00 per share in cash or approximately $1.3 billion on a fully diluted basis, which represents a 32% premium to the trailing 30-trading-day volume weighted average price (VWAP) of $10.62 per share for Cadence Pharmaceuticals, Inc.
› Verified 8 days ago